Similar articles for PMID: 21466501

Year	Number of Results
2000	3
2002	1
2003	4
2004	3
2006	5
2007	3
2008	5
2009	7
2010	12
2011	12
2012	10
2013	4
2014	9
2015	4
2016	4
2017	3
2018	5
2019	4
2020	4
2021	3
2022	4
2023	2
2024	1

1

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Yokell MA, Zaller ND, Green TC, Rich JD. Yokell MA, et al. Curr Drug Abuse Rev. 2011 Mar;4(1):28-41. doi: 10.2174/1874473711104010028. Curr Drug Abuse Rev. 2011. PMID: 21466501 Free PMC article. Review.

2

From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B. Ling W, et al. J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S53-60. doi: 10.1016/j.jsat.2010.01.009. J Subst Abuse Treat. 2010. PMID: 20307796 Free PMC article.

3

Prescription of Controlled Substances: Benefits and Risks.

Preuss CV, Kalava A, King KC. Preuss CV, et al. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30726003 Free Books & Documents.

4

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.

Mammen K, Bell J. Mammen K, et al. Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405. Expert Opin Pharmacother. 2009. PMID: 19708849 Review.

5

Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.

Balhara YP. Balhara YP. J Opioid Manag. 2013 Jul-Aug;9(4):237. J Opioid Manag. 2013. PMID: 24380101 No abstract available.

6

Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?

Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Taylor LE, et al. J Addict Med. 2012 Sep;6(3):179-85. doi: 10.1097/ADM.0b013e318257377f. J Addict Med. 2012. PMID: 22614935 Free PMC article.

7

Buprenorphine and naloxone for heroin dependence.

Johnson RE, McCagh JC. Johnson RE, et al. Curr Psychiatry Rep. 2000 Dec;2(6):519-26. doi: 10.1007/s11920-000-0012-8. Curr Psychiatry Rep. 2000. PMID: 11123005 Review.

8

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T. Amass L, et al. Am J Addict. 2004;13 Suppl 1(Suppl 1):S42-66. doi: 10.1080/10550490490440807. Am J Addict. 2004. PMID: 15204675 Free PMC article.

9

Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.

Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P. Stimolo C, et al. Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000. Clin Drug Investig. 2010. PMID: 20450243

10

Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.

Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Bazazi AR, et al. J Addict Med. 2011 Sep;5(3):175-80. doi: 10.1097/ADM.0b013e3182034e31. J Addict Med. 2011. PMID: 21844833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year